首页> 外文期刊>Chemistry central journal >Photostability and toxicity of finasteride, diclofenac and naproxen under simulating sunlight exposure: evaluation of the toxicity trend and of the packaging photoprotection
【24h】

Photostability and toxicity of finasteride, diclofenac and naproxen under simulating sunlight exposure: evaluation of the toxicity trend and of the packaging photoprotection

机译:非那雄胺,双氯芬酸和萘普生在模拟阳光照射下的光稳定性和毒性:评估毒性趋势和包装的光防护性能

获取原文
           

摘要

Background Drugs photostability plays two different opposite roles; a real advantage arises considering the longer expiration time of the drugs while the consequent persistence in the environment involves an obvious negative effect bound to their harmfulness. On this basis we tested the photostability and toxicity of three pharmaceutical active principles: Finasteride, Diclofenac and Naproxen. The pure active principles, as well as commercial drugs containing them, were considered; for the last, the protective effect of the packaging was also evaluated. Samples were irradiated according to the ICH Guidelines for photostability testing (The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use); a simulating sunlight source (a mercury-vapor lamp coupled to a tungsten filament one) was used to cover the wavelength range 300–2000 nm; Temperature, Relative Humidity, Irradiance and Illuminance were maintained constant during the photodegradation. The concentrations of the pharmaceutical active principles during the photodegradation were monitored by HPLC with UV/Vis detector. Toxicity tests were performed by means of an amperometric biosensor based on suspended yeast cells. Since the products obtained by the photodegradation process can result as toxic or more toxic than the original molecules, tests were performed first and after the photodegadation. Results After 90 hours of exposure the concentration resulted lowered by 42.9%, 88.4% and 91% for Finasteride, Naproxen and Diclofenac respectively. Toxicity of the pure active principles follows the same order of the photostability. After photodegradation a contribute of the reaction products was evidenced. Conclusions The simple and cheap analytical procedure here proposed, allowed to obtain not only data on photostability and toxicity of the pure active principles but, even if roughly, also useful information on the reactions kinetic and toxicity of the photodegradation products.
机译:背景药物的光稳定性起着两个不同的相反作用。考虑到药物的有效期更长,真正的优势出现了,而随之而来的在环境中的持久性则带来了明显的不利于其危害的负面影响。在此基础上,我们测试了三种药物活性成分(非那雄胺,双氯芬酸和萘普生)的光稳定性和毒性。考虑了纯活性成分以及包含它们的商业药物;最后,还评估了包装的保护效果。根据ICH的光稳定性测试指南(国际人用药品注册技术要求统一会议)对样品进行辐照;一个模拟太阳光源(一个汞蒸气灯和一个钨丝灯相连)用于覆盖300-2000 nm的波长范围;在光降解过程中,温度,相对湿度,辐照度和照度保持恒定。通过具有UV / Vis检测器的HPLC监测光降解过程中药物活性成分的浓度。借助于基于悬浮酵母细胞的安培生物传感器进行毒性测试。由于通过光降解过程获得的产物可能会比原始分子有毒或更具有毒性,因此首先在光降解之后进行测试。结果暴露90小时后,非那雄胺,萘普生和双氯芬酸的浓度分别降低了42.9%,88.4%和91%。纯活性成分的毒性遵循光稳定性的相同顺序。光降解后,反应产物得到了证实。结论本文提出的一种简单而廉价的分析方法,不仅可以获得纯活性成分的光稳定性和毒性数据,而且即使粗略地也可以获得有关光降解产物的反应动力学和毒性的有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号